Close

Council

The Council is the governing body of the School and has overall responsibility for its operational and strategic management.

Credit: Anne Koerber/LSHTM

Council members fulfil their roles in accordance with the constitutional document of this Higher Education Institution (HEI), its Royal Charter, and subject to regulations for the operation of an HEI as determined by government and other external agencies.

The governing body of the School is its Council which is supported by various sub-committees.

Members

Dame Marjorie Scardino (Chairman)

Marjorie Scardino was for 12 years chief executive of The Economist Group (first in America and then worldwide). After that she was, for 16 years, the chief executive of Pearson plc, the world's leading education company and the owner of Penguin books and The Financial Times Group and half of The Economist.

She retired from her Pearson position on January 1, 2013, and is currently the chairman of The MacArthur Foundation. MacArthur is one of the world's largest independent foundations, working on wide-ranging programs from community and economic development to digital learning to juvenile justice to international human rights, peace and security and environmental conservation. She is also chairman of the London School of Hygiene and Tropical Medicine, a 116-year-old organisation that is one of the world's most admired public health and global health research postgraduate institutions.

She is also a member of the non-profit boards of Pure Tech Health Inc.; The Royal College of Art; The Carter Center; on the Visiting Committee for the MIT Media Lab; Bridge International Academies (HQ – Kenya) and a member of the for-profit boards of IAG (comprising British Airways, Iberia and other airlines) and Twitter (the social media company).

Dame Marjorie was raised in Texas, trained as a lawyer and practiced in Georgia for a decade. She also began and ran there, with her husband, the Pulitzer-prize-winning Georgia Gazette newspaper. She has received a number of awards and honorary degrees from British and American universities and organisations, and in 2003 was made a Dame of the British Empire. She is also a member of the Royal Society of the Arts in the UK and the American Association of Arts and Sciences in America.

Dr Diana Walford (Deputy Chair)

Diana Walford has been a member of Council since 2009 and Deputy Chairman from 2010. Her long association with the School started in 1986 when, on sabbatical from the Department of Health (DH), she read for an MSc in Epidemiology. From 1989-2002 she was the Secretary of State’s nominee on the School’s Board of Management and from 2005-09 a co-opted member of the Court of Governors.

Trained as a haematologist, Diana spent sixteen years in the DH in a variety of senior posts, including as Head of the Division dealing with communicable diseases and the newly emerging HIV and AIDS. In 1989 she was appointed Deputy Chief Medical Officer for England and Director of Healthcare on the NHS Management Executive. In 1992 she became Director of the Public Health Laboratory Service (PHLS), leaving in 2002 to become Principal of Mansfield College, Oxford University. That year she was awarded CBE for services to public health. From 2005-09 she served on the NHS Blood and Transplant Authority Board. On retirement from Mansfield College in 2011 she was appointed a Non-Executive Director at UCLH NHS Foundation Trust and is also a Trustee of Sue Ryder and a member of the State Honours Committee.

Ms Ann Grant

Ann Grant worked at Standard Chartered Bank from 2005 – 2014, as Vice Chairman for Africa. Her earlier career was as a British diplomat. She joined the UK Diplomatic Service in 1971, with subsequent postings in India, Mozambique, Brussels (European Union) and New York (UK Mission to the UN). She also worked for two years as Communications Director for Oxfam UK in the late 1980s. From 1998 – 2000 she was Director for Africa and the Commonwealth at the UK Foreign Office, and from 2000 – 2005 was British High Commissioner to South Africa.

Ann is a member of the Boards of the Overseas Development Institute, London School of Hygiene and Tropical Medicine, and the Rift Valley Institute. She is the Senior Independent Director at Tullow Oil, and chairs the Serious Music Trust.

Mr John O’Donnell

John O’Donnell joined the Council of the School in 2011 and is the Chief Commercial Officer and General Counsel of Achilles Information. Achilles creates and manages a global network of collaborative industry communities, and provides validated data and insightful analytics to enable buyers to manage risk, and suppliers to increase market reach.

Prior to joining Achilles he was Business Development Director at Reed Elsevier, a senior executive at Accenture and a lawyer at NDS (News Digital Systems). John began his career as a trainee solicitor with Matheson, a leading Dublin law firm. He holds a BA and LLB from University College Galway, an LLM in Commercial Laws from Queen Mary University of London, and was admitted as a solicitor by the Law Society of Ireland in 1994.

Mr Paul Klingenstein

Paul Klingenstein is founder and managing partner of Aberdare Ventures, a healthcare technology venture capital firm based in San Francisco.  He started the firm in 1999 after a period at the Rockefeller Foundation, where he advised on the initial public-private partnerships and impact investment funds.  Earlier, he was a managing partner at Accel Partners in San Francisco and was employed by Warburg Pincus in New York.  He has served on boards of numerous healthcare technology companies from startup to commercial stage, engaged in such areas as drug discovery, diagnostics, interventional devices, and information tools.

In the late 1990s, Mr. Klingenstein advised on private sector healthcare initiatives in India, China, and Malaysia.  In the late 1970s, he worked as a field biologist in Tanzania, Kenya, and Uganda.  He has served on the boards of various educational and nonprofit institutions, including the African Wildlife Foundation, Juma Ventures (former Chair), The Marin Country Day School, and the Taft School. Mr. Klingenstein is currently a director of the MacArthur Foundation and the Campaign Legal Center. He is the former Board Chair of the International AIDS Vaccine Initiative, a global organization that supports discovery science, clinical testing, advocacy, and policy in support of an HIV vaccine.

Mr. Klingenstein holds an A.B. degree in Anthropology from Harvard and an MBA from Stanford.  He is a proprietor of the Ishawooa Mesa and the Darwin Ranches, both in northwestern Wyoming.

Mr Jon Roper

Jonathan Roper was a partner in the international law firm Eversheds LLP, specialising in merger and acquisition work for UK and overseas clients for over 30 years until his retirement from the firm in 2011. He is currently a director of Rights and Issues Investment Trust plc, a quoted investment trust investing in small and mid-cap companies and a Trustee of Hospice in the Weald, a charitable company providing hospice care in West Kent and East Sussex.

Director

Peter Piot MD PhD is the Director of the London School of Hygiene & Tropical Medicine, and Professor of Global Health. He was the founding Executive Director of UNAIDS and Under Secretary-General of the United Nations from 1995 until 2008, and was an Associate Director of the Global Programme on AIDS of the World Health Organization.

Professor Piot co-discovered the Ebola virus in Zaire in 1976, and led research on AIDS, sexually transmitted infections, women’s health, and public health in Africa. He was a professor of microbiology, public health and global health at the Institute of Tropical Medicine, Antwerp, the University of Nairobi, and Imperial College London, was a Senior Fellow at the University of Washington, a Senior Fellow at the Bill and Melinda Gates Foundation, and held the chair “Knowledge against poverty” at the College de France in Paris.

He is a member of the US National Academy of Medicine, of the Académie Nationale de Médecine of France, and of the Royal Academy of Medicine of his native Belgium, and a fellow of the Academy of Medical Sciences, UK, and the Royal College of Physicians. He was President of the International AIDS Society in 1991-1994. In 2008-11, he was the President of the King Baudouin Foundation. He has published over 580 scientific articles and 17 books, including his memoir “No time to lose” and "Aids between science and politics". He was the recipient of the Hideyo Noguchi Africa Prize for Medical Research, the Prince Mahidol Award, the Canada Gairdner Global Health Award, the Calderone Prize, the INSERM International Prize, and the Robert Koch Gold Medal, the Sir Patrick Manson Medal, and the Bloomberg Hopkins Centennial Award, and was a 2014 Time Person of the Year. He was knighted as a baron in Belgium in 1995 and received an honorary knighthood in 2016.

 

Sir Andrew Witty

Andrew is Chancellor of the University of Nottingham and recently retired as Chief Executive Officer of GlaxoSmithKline plc a position he held between 2008 and 2017.

Andrew joined Glaxo in 1985 and held a variety of roles in the UK and overseas, including South Africa, the USA and Singapore. During his tenure GSK consistently achieved the Top Position in every Access to Medicine Index.

While in Singapore Andrew was also a Board Member of the Singapore Economic Development Board and the Singapore Land Authority. In 2003 he was awarded the Public Service Medal by the Government of Singapore and then in August 2012 was awarded the Public Service Star.

Andrew has served in numerous advisory roles to governments around the world including South Africa, Guangzhou China and the UK, where he was a member of the Prime Minister’s Business Advisory Group from 2010 - 2015. In 2012 Andrew was awarded a knighthood for services to the economy and the UK pharmaceutical industry. In 2014, he was appointed as a Business Ambassador for the UK Government and in 2015 Andrew became a Member of the Advisory Council for the China-Britain Business Council.

Andrew was President of the European Federation of Pharmaceutical Industries and Associations from 2010 to 2013. From 2013 to 2015 he was the only pharmaceutical industry representative in the UNAIDS–Lancet Commission for Defeating AIDS and Advancing Global Health. In November 2015 Andrew was appointed as a Member of the UN High-Level Panel on Access to Medicines. In May 2016, Andrew became a Visiting Professor at the Institute of Global Health Innovation at Imperial College, London. He is a Non Executive Director of United Healthcare and G1 Therapeutics and Council Member of the London School of Health and Tropical Medicine.

Andrew has a Joint Honours BA in Economics from the University of Nottingham and holds Honorary Degrees from the Universities of Exeter, Manchester and Nottingham.

Dr Wendy R Ewart

Following degrees from Southampton University and Bristol University  (BSc Hons  Physiology and Biochemistry, PhD in Neuroscience) Dr Ewart’s professional career has been in biomedical research.  After an academic career at Queen Mary University of London Medical School she moved into funding medical research funding and held a senior management position at the Wellcome Trust managing  funding portfolios in neuroscience and mental health and also global health. In 2003 she moved to Imperial College Faculty of Medicine as Head of Research Strategy  working closely alongside leading researchers at Imperial to develop the faculty’s strengths and research profile.  2008 signalled a return to research funding at the UK  Medical Research Council, as Chief of Strategy and was subsequently promoted to Deputy Chief Executive.  Whilst at the MRC Dr Ewart was on the boards of The Crick Institute, and, UK Biobank.

Dr Ewart has experience at Board level in the NHS having served as a non executive director on the board of a local acute NHS district hospital for seven years; for the last year as chair of the Board.

Since stepping down from the MRC in 2014, she has been advising on science for the Welsh Government:  as a member of the Science Advisory Council for Wales, as Chair of the Independent Review panel for Ser Cyrmu 2 – an 80 million Euro funding scheme to support rising stars in science research in Welsh universities and currently as a member of the 2017 Reid Review of Welsh science.

Dr Ewart is also currently on the board of the charity Africa Research Excellence Fund (AREF).

Dr Ewart was appointed MBE in the June 2015 Birthday honours list for services to medical research. Also in June 2015 she was made a Fellow of the Faculty of Medicine, Imperial College.  In July 2016 Dr Ewart was awarded an Honorary DSc from the University of Bristol.

Dr Precious Lunga

Dr Precious Lunga is CEO and Co-Founder of Baobab Circle, a health technology company using mobile phones to deliver innovative health solutions across Africa. Previously she was at Econet Wireless where she established the mHealth business unit to deliver health services across the mobile phone network. Whilst at Econet she established a mobile health platform in Zimbabwe and Lesotho which attracted more than 750,000 customers within its first year of launch.

Dr Lunga trained as a neuroscientist and epidemiologist. She has worked as a lab research scientist in the biotech industry and academia. As an epidemiologist at the Medical Research Council Clinical Trials Unit Precious was involved in conducting large scale multi-centre HIV microbicide prevention clinical trials in Eastern and Southern Africa. This was followed by a period of working at UNAIDS Geneva where she was involved in spearheading the implementation of male circumcision for HIV prevention.

She has been strategic advisor at the Children’s Investment Fund Foundation funding health programmes across Africa.  Dr Lunga is an advocate for the use of technology to improve access to health. She has been featured at the Women of the World festival and media programs including the BBC World Service Forum Programme and Sky News.

Dr Lunga is a member of the boards of the London School of Hygiene and Tropical Medicine, Malaria Consortium, and Grassroots Soccer UK. She also sits on the Advisory Board for Weidenfeld-Hoffman Trust’s Leadership and Scholarships Programme.

Dr Lunga has a PhD in Neuroscience from Cambridge University, MSc Epidemiology from the London School of Hygiene and Tropical Medicine and a BSc (Hons) Neuroscience from Edinburgh University. She is a Yale World Fellow.

Chairman of the Student Representative Council
  • To be elected
Lucinda Parr (Secretary and Registrar)

Lucinda Parr is the Secretary and Registrar, responsible for academic and corporate governance, Student and Academic Services, Health and Safety and Legal Services, a post she was appointed to in October 2016.

Prior to this she was Director of Executive and Governance Services at Goldsmiths, University of London. She shares responsibility with the Chief Operating Officer for the effective and efficient delivery of the School/s professional services and is also the Secretary to the statutory bodies of the institution and a member of the Senior Leadership Team. Lucinda read Music and holds a MMus in Historical Musicology from Goldsmiths.

She is also a member of the Leadership Foundations Governor’s Advisory Forum and a non-executive Director of Mulberry UTC.

Elected staff members
  • Professor Alison Grant
  • Professor Susannah Mayhew
  • Professor Richard White
  • Gemma Donaldson